Patents Assigned to NOVOCELL Bio Co., Ltd.
  • Publication number: 20230364142
    Abstract: The present invention relates to an antiviral composition comprising Natural Killer (NK) cells as an active ingredient and, more particularly, to a composition for preventing or treating COVID-19 virus (SARS-CoV-2) infection comprising NK cells as an active ingredient and a method for culturing lymphocytes comprising anti-COVID-19 virus NK cells.
    Type: Application
    Filed: April 12, 2023
    Publication date: November 16, 2023
    Applicant: NOVOCELL Bio Co., Ltd.
    Inventor: Guy Young MOON